On the other hand, Ritonavir exhibits a cytostatic and cytotoxic action on glioma cells through the inhibition of the chymotrypsin-like activity of the proteasome [22] and exerts synergistic activity with Aprepitant in inhibiting glioma cell growth by decreasing Akt signaling [23]. Here, AKT1 is linked to central nervous system cancer.